Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

Life Science seminar

By Emilie Håkonsson LohseSoMe & Communication Coordinator

Do you want to know more about the latest development in the Nordic Life Science industry? Get an update on HC Andersen Capital's view on valuation as well as presentations from listed Life Science companies focussing on their late-stage pipeline.

We have the pleasure of welcoming Bavarian Nordic, Gubra, ExpreS2ion Biotechnologies, Ascelia Pharma, Pharma Equity Group, Curasight, Hansa Biopharma, Qlife, Index Pharmaceuticals, NeoDynamics and BioPorto.

You can find the agenda for the seminar here.

Disclaimer: HC Andersen Capital receives payment from the attending companies for a Digital IR/corporate visibility agreement.

Stay up to date
Bavarian Nordic
Gubra
ExpreS2ion Biotech Holding
Ascelia Pharma
Pharma Equity Group
Curasight
BioPorto
Hansa Biopharma
Qlife Holding
Flerie
NeoDynamics

Recent videos

Scanfil Q4’25: Horizontal operational progress
2026-03-09 10:26 Scanfil
Aiforia, Webcast, H2, 2025
2026-03-06 09:00 Aiforia Technologies
VD Intervju: Lär känna W5 Solutions på djupet
2026-03-06 08:11 W5 Solutions
Solwers Q4'25: Fokus på lönsamhet och organisk tillväxt
2026-03-05 13:42
Nightingale, Webcast, Half-year financial report 1 July–31 December 2025
2026-03-05 13:00 Nightingale Health
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.